Barbara E Bierer

Barbara Emily Bierer, MD

Professor of Medicine (Pediatrics), HMS
Member, HMS Center for Bioethics

Barbara Bierer, MD is a Professor of Medicine (Pediatrics) at Harvard Medical School (HMS), and a hematologist/oncologist at the Brigham and Women's Hospital (BWH). She received her MD from HMS. She is the director of the Regulatory Foundations, Law and Ethics Program of the Harvard Catalyst, the Harvard Clinical and Translational Science Award, and the director of regulatory policy, SMART IRB. Dr. Bierer co-founded and now leads the Multi-Regional Clinical Trials Center of BWH and Harvard (MRCT Center), a University-wide and collaborative effort to improve the ethics, conduct, and regulatory environment for multi-site, multi-national clinical trials. She is a co-founder of COVID-19 Collaboration Platform, a platform for cooperation in research. In 2017, the MRCT Center launched the non-profit Vivli, a global clinical research data sharing platform. From 2003-2014, she served as Senior Vice President, Research, at BWH and was the institutional official for human subjects and animal research, for biosafety and for research integrity at the BWH. She initiated the Brigham Research Institute and the Innovation Hub (iHub), a focus for entrepreneurship and innovation. Dr. Bierer established and directed the Center for Faculty Development and Diversity at the BWH; for these efforts, she was the first recipient of the HMS Harold Amos Faculty Diversity Award.

Publications View
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Authors: Authors: Winston DJ, Antin JH, Wolff SN, Bierer BE, Small T, Miller KB, Linker C, Kaizer H, Lazarus HM, Petersen FB, Cowan MJ, Ho WG, Wingard JR, Schiller GJ, Territo MC, Jiao J, Petrarca MA, Tonetta SA.
Bone Marrow Transplant
View full abstract on Pubmed
T cell signal transduction and the role of CD7 in costimulation.
Authors: Authors: Stillwell R, Bierer BE.
Immunol Res
View full abstract on Pubmed
The involvement of the proto-oncogene p120 c-Cbl and ZAP-70 in CD2-mediated T cell activation.
Authors: Authors: Lin H, Martelli MP, Bierer BE.
Int Immunol
View full abstract on Pubmed
The actin cytoskeleton, membrane lipid microdomains, and T cell signal transduction.
Authors: Authors: Morley SC, Bierer BE.
Adv Immunol
View full abstract on Pubmed
T-lymphocyte coactivator molecules.
Authors: Authors: Salazar-Fontana LI, Bierer BE.
Curr Opin Hematol
View full abstract on Pubmed
Signaling via LAT (linker for T-cell activation) and Syk/ZAP70 is required for ERK activation and NFAT transcriptional activation following CD2 stimulation.
Authors: Authors: Martelli MP, Lin H, Zhang W, Samelson LE, Bierer BE.
Blood
View full abstract on Pubmed
Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts.
Authors: Authors: Ouyang Y, Virasch N, Hao P, Aubrey MT, Mukerjee N, Bierer BE, Freed BM.
J Allergy Clin Immunol
View full abstract on Pubmed
Failure of gelsolin overexpression to regulate lymphocyte apoptosis.
Authors: Authors: Posey SC, Martelli MP, Azuma T, Kwiatkowski DJ, Bierer BE.
Blood
View full abstract on Pubmed
EB1 proteins regulate microtubule dynamics, cell polarity, and chromosome stability.
Authors: Authors: Tirnauer JS, Bierer BE.
J Cell Biol
View full abstract on Pubmed
Yeast Bim1p promotes the G1-specific dynamics of microtubules.
Authors: Authors: Tirnauer JS, O'Toole E, Berrueta L, Bierer BE, Pellman D.
J Cell Biol
View full abstract on Pubmed